Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
Insurance companies can no longer implement harmful co-pay accumulator policies.
A look at the competing initiatives, including Medicare for All.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
A statement from the Partnership to End HIV, STDs and Hepatitis
It’s going to take more than condoms to end the HIV epidemic in the U.S.
A proposed change to Medicare Part D will make our HIV treatment harder. Here’s how to make your objection heard.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
The president’s proposed Medicare Part D rule will restrict access to HIV meds. AIDS United wants him to withdraw it.
Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.
A roundup of statements
Expand health care access; withdraw Medicare Part D changes.
More than 250,000 people living with HIV would be affected by a proposed rule change to Medicare Part D.
To quote the president: SAD!
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.